• Return to Headlines

Depomed Shares Down 54.7% Since SmarTrend's Sell Call (DEPO)

By Amy Schwartz

SmarTrend identified a Downtrend for Depomed (NASDAQ:DEPO) on October 28th, 2016 at $22.73. In approximately 7 months, Depomed has returned 54.73% as of today's recent price of $10.29.

Over the past year, Depomed has traded in a range of $9.50 to $33.74 and is now at $10.29, 8% above that low. In the last five trading sessions, the 50-day moving average (MA) has fallen 0.2% while the 200-day MA has slid 1.6%.

DepoMed, Inc. develops new and proprietary oral drug delivery technologies. The Company has developed a system designed to be retained in the stomach for an extended period of time while it delivers the incorporated drug or drugs. DepoMed has also developed a system designed to reduce gastrointestinal irritation.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any changes in momentum for shares of Depomed.

Log in and add Depomed (DEPO) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights DepoMed

Ticker(s): DEPO